2017
DOI: 10.24170/14-2-2498
|View full text |Cite
|
Sign up to set email alerts
|

Cardiomyocyte differentiation: Experience and observations from 2 laboratories

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 23 publications
0
6
0
Order By: Relevance
“…Despite the latest attempts to optimize PCM isolation, unstable quality and low cell yield are major hurdles that preclude the use of PCMs in nonacute in vitro experiments. , In this scenario, H9c2 surpasses other existing cardiac cell lines (e.g., HL-1, AC16) , and can be further matured toward a cardiomyocyte-like phenotype when treated with retinoic acid (RA). , However, it was brought to our attention that recent studies using H9c2 cells to test distinct biomaterials for cardiac applications did not induce such a cardiomyocyte differentiation, , suggesting plausible difficulties to mature H9c2 cells when grown onto engineered substrates. Additionally, other laboratories reported discrepancies when reproducing H9c2 maturation to cardiomyocytes, , indicating some degree of resistance to differentiation. Nevertheless, H9c2 differentiation is imperative to achieve a better resemblance to adult cardiac tissue and perform investigations with higher translational value.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Despite the latest attempts to optimize PCM isolation, unstable quality and low cell yield are major hurdles that preclude the use of PCMs in nonacute in vitro experiments. , In this scenario, H9c2 surpasses other existing cardiac cell lines (e.g., HL-1, AC16) , and can be further matured toward a cardiomyocyte-like phenotype when treated with retinoic acid (RA). , However, it was brought to our attention that recent studies using H9c2 cells to test distinct biomaterials for cardiac applications did not induce such a cardiomyocyte differentiation, , suggesting plausible difficulties to mature H9c2 cells when grown onto engineered substrates. Additionally, other laboratories reported discrepancies when reproducing H9c2 maturation to cardiomyocytes, , indicating some degree of resistance to differentiation. Nevertheless, H9c2 differentiation is imperative to achieve a better resemblance to adult cardiac tissue and perform investigations with higher translational value.…”
Section: Resultsmentioning
confidence: 99%
“…45,46 However, it was brought to our attention that recent studies using H9c2 cells to test distinct biomaterials for cardiac applications did not induce such a cardiomyocyte differentiation, 40,81−84 suggesting plausible difficulties to mature H9c2 cells when grown onto engineered substrates. Additionally, other laboratories reported discrepancies when reproducing H9c2 maturation to cardiomyocytes, 76,85 indicating some degree of resistance to differentiation. Nevertheless, H9c2 differentiation is imperative to achieve a better resemblance to adult cardiac tissue and perform investigations with higher translational value.…”
Section: ■ Introductionmentioning
confidence: 99%
“…Multinucleation of H9c2 cells is considered as a morphological indication of its differentiation to cardiac lineage rather than to a rhabdomyocyte lineage 30 . Previous reports have shown the increased expression of cardiac‐specific proteins such as myosin light chain‐2v and cardiac troponin‐T together with a shift in metabolic preference from glycolytic to oxidative metabolism 31 during differentiation towards cardiomyocytes. In this study, the differentiated cells showed increased expression of troponin‐T, myo‐D, and connexin 43 indicative of cardiomyocyte‐lineage specific proteins (Figure 3D).…”
Section: Discussionmentioning
confidence: 99%
“…10 6 cells were plated and after reaching 80% confluence, differentiation was induced for 7 days by the reduction of fetal bovine serum to 1% and the addition of 1 μmol L −1 of retinoic acid (Sigma-Aldrich) to the culture medium. The differentiation medium was changed every 2 days ( Pereira et al, 2011 ; Suhaeri et al, 2015 ; Patten et al, 2017 ). The cells (cardiomyocytes) were then separated into three groups treated with 100 μmol L −1 H 2 O 2 (Merck) for 1 h ( Oraki Kohshour et al, 2013 ; Ilavenil et al, 2015 ), 10 μmol L −1 of isoproterenol (Sigma-Aldrich) for 48 h ( Chen et al, 2012 ), and 1 μmol L −1 of doxorubicin (Sigma-Aldrich) for 12 h ( Jiang et al, 2020 ).…”
Section: Methodsmentioning
confidence: 99%